What is the treatment for Hemophilia A?

Hemophilia A is a hereditary bleeding disorder caused by a deficiency in factor VIII, a crucial protein for blood clotting. The primary treatment involves replacing the missing factor to promote proper coagulation.

Factor VIII therapy is specifically indicated for individuals with Hemophilia A to manage bleeding episodes and prevent future complications. This factor can be administered through intravenous infusions during acute bleeding events or prophylactically to prevent bleeding.

While DDAVP (Desmopressin) can also be used in some mild cases of Hemophilia A to stimulate the release of endogenous factor VIII, the definitive treatment for more severe cases remains factor VIII replacement. Factor IX is relevant to Hemophilia B, not A, and vitamin K is vital for synthesizing several clotting factors but does not directly address factor VIII deficiency in Hemophilia A. Thus, the most appropriate choice for the treatment of Hemophilia A is factor VIII.